300436 Fujian Cosunter Pharmaceutical
- 30.53
- +0.71+2.38%
About Fujian Cosunter Pharmaceutical Company
The company was founded in 2001 and is a national key high-tech enterprise listed on the Shenzhen Stock Exchange. The company has a national enterprise technology center and has been continuously rated as a model enterprise for national intellectual property advantages for many years; at the same time, it has established companies for innovative drugs, APIs, and proprietary Chinese medicines. Adhering to the corporate mission of “broadcasting benevolence and focusing on people's livelihood”, the company firmly believes in the dream of providing scientific solutions for human liver health, unswervingly promotes innovative drug research and development, implements innovative development strategies, and is committed to fighting the coronavirus, hepatitis B, liver cancer, and liver fibrosis, creating innovative drugs belonging to the Chinese people, and contributing core strength to the innovation and development of independent and controllable drugs in China. The company's main products: anti-hepatitis B virus drugs, hepatoprotective drugs, men's health drugs, cardiovascular drugs, etc. Corporate honors: China Patent Excellence Award; High-tech Enterprise Certificate; Second Prize of Fujian Patent Award; Third Prize of Fujian Science and Technology Progress Award, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- guoping li
- Chairman, Directors, General Manager, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
- 1.20M
- liqing ye
- Directors, Audit Committee Member
- --
- chenming zhuang
- Directors, Deputy General Manager
- --
- guodong li
- Directors, Strategy Committee Member, Nomination Committee Members, Audit Committee Member
- 423.60K
- hongming li
- directors, Chief Operating Officer (COO)
- 1.85M
- fuhu huang
- Directors, Deputy General Manager, Strategy Committee Member
- 1.58M
- hongjun wu
- Independent Directors, Chairman of the Audit Committee, Chairman of the Remuneration and Assessment Committee
- --
- feimei wu
- Independent Directors, Audit Committee Member, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- --
- fengmin lu
- Independent Directors, Audit Committee Member, Strategy Committee Member, Chairman of the Nomination Committee
- --
- qinghe zhang
- Board Secretary, Deputy General Manager
- 481.30K
- shijun wu
- Securities Affairs Representative
- --
- baoming shi
- Chairman of the Supervisory Board, Auditors
- --
- houlin xiao
- Auditors
- --
- bingxiang ceng
- Deputy General Manager
- 549.60K
- jianhui guan
- Chief Financial Officer
- 790.70K
- meixiang lu
- Head of Internal Audit
- --
- weizhong mao
- Chief Scientist, Chief Development Officer
- 1.98M
- haifeng lin
- Employee Supervisors
- 303.60K
No Data
